Marcos Lopes de Miranda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Marcos Lopes de Miranda has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
Eliete Bouskela
From the Laboratory for Clinical and Experimental Research in Vascular Biology - BioVasc, Department of Physiological Sciences, Biomedical Center, Rio de Janeiro State University, Rio de Janeiro, Brazil (M.L.M., D.S.B., L.S.P., M.-C.S.S., E.B.); and Internal Medicine Department, Andaraí Federal Hospital, Rio de Janeiro, Brazil (M.M.B.).
3 shared publications- Eliete Bouskela
Postgraduate Program in Clinical and Experimental Physiopathology, Faculty of Medical Sciences, State University of Rio de Janeiro, Rio de Janeiro, Brazil
2 shared publications - Luiz Guilherme Kraemer-Aguiar
Postgraduate Program in Clinical and Experimental Physiopathology, Faculty of Medical Sciences State University of Rio de Janeiro Rio de Janeiro Brazil
2 shared publications M.D. Michelle M. Balarini
From the Laboratory for Clinical and Experimental Research in Vascular Biology - BioVasc, Department of Physiological Sciences, Biomedical Center, Rio de Janeiro State University, Rio de Janeiro, Brazil (M.L.M., D.S.B., L.S.P., M.-C.S.S., E.B.); and Internal Medicine Department, Andaraí Federal Hospital, Rio de Janeiro, Brazil (M.M.B.).
2 shared publications- Michelle de Moura Balarini
Hospital Universitário Pedro Ernesto, Brasil
2 shared publications - Nivaldo Ribeiro Villela
Laboratory for Clinical and Experimental Research in Vascular Biology - BioVasc, Biomedical Center, Rio de Janeiro State UniversityRio de Janeiro, Brazil; Anesthesiology, Department of Surgery, Faculty of Medical Sciences, Rio de Janeiro State UniversityRio de Janeiro, Brazil
2 shared publications
Latest Publications
- Open Access
- 1 January 2025
- Published by Even3 in Revista Brasileira de Estudos da Homocultura
- Vol. 8 (23)
Criação e implementação do ambulatório trans da Universidade do Estado do Rio de Janeiro: experiência do Ambulatório Identidade Transdiversidade
A transfobia no sistema de saúde, manifestada por práticas discriminatórias e abordagens patologizantes, evidencia a carência de unidades de atendimento que respeitem a individualidade da população trans e superem barreiras de acesso. Este trabalho relata a experiência de criação e implementação do Ambulatório Identidade Transdiversidade na Universidade do Estado do Rio de Janeiro, visando inspirar iniciativas similares. A operacionalização do projeto incluiu a formação de equipe multidisciplinar e o estabelecimento de protocolos de atendimento personalizados, com foco na saúde integral do indivíduo trans. Capacitação contínua e participação ativa da comunidade trans foram fundamentais no processo. Em poucos meses, um número expressivo de atendimentos foi realizado, indicando importante demanda reprimida. Os feedbacks extremamente positivos dos usuários trans demonstram a eficácia do ambulatório em atender as suas necessidades específicas. Conclui-se que o Identidade foi um marco na promoção da saúde trans, reduzindo o estigma e aprimorando a qualidade do atendimento.
- 1 January 2025
- Published by Even3 in Revista Brasileira de Estudos da Homocultura
- Vol. 8 (23)
Open AccessCriação e implementação do ambulatório trans da Universidade do Estado do Rio de Janeiro: experiência do Ambulatório Identidade Transdiversidade
A transfobia no sistema de saúde, manifestada por práticas discriminatórias e abordagens patologizantes, evidencia a carência de unidades de atendimento que respeitem a individualidade da população trans e superem barreiras de acesso. Este trabalho relata a experiência de criação e implementação do Ambulatório Identidade Transdiversidade na Universidade do Estado do Rio de Janeiro, visando inspirar iniciativas similares. A operacionalização do projeto incluiu a formação de equipe multidisciplinar e o estabelecimento de protocolos de atendimento personalizados, com foco na saúde integral do indivíduo trans. Capacitação contínua e participação ativa da comunidade trans foram fundamentais no processo. Em poucos meses, um número expressivo de atendimentos foi realizado, indicando importante demanda reprimida. Os feedbacks extremamente positivos dos usuários trans demonstram a eficácia do ambulatório em atender as suas necessidades específicas. Conclui-se que o Identidade foi um marco na promoção da saúde trans, reduzindo o estigma e aprimorando a qualidade do atendimento.
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Revista Brasileira de Educação Médica
- Vol. 48 (3) , e088
Qualidade da residência médica na perspectiva das partes interessadas: revisão de escopo e painel Delphi
Embora na literatura médica existam diversas métricas para avaliar a qualidade dos programas de residência, os instrumentos avaliativos tendem a focar as dimensões dos residentes e preceptores. Isso negligencia uma ampla gama de partes interessadas (stakeholders), cujas perspectivas são fundamentais para uma compreensão holística da qualidade dos programas.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Revista Brasileira de Educação Médica
- Vol. 48 (3) , e088
Open AccessQualidade da residência médica na perspectiva das partes interessadas: revisão de escopo e painel Delphi
Embora na literatura médica existam diversas métricas para avaliar a qualidade dos programas de residência, os instrumentos avaliativos tendem a focar as dimensões dos residentes e preceptores. Isso negligencia uma ampla gama de partes interessadas (stakeholders), cujas perspectivas são fundamentais para uma compreensão holística da qualidade dos programas.
- Open Access
- 1 January 2017
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 126 (1) , 140-149
Ivabradine Attenuates the Microcirculatory Derangements Evoked by Experimental Sepsis
Background: Experimental data suggest that ivabradine, an inhibitor of the pacemaker current in sinoatrial node, exerts beneficial effects on endothelial cell function, but it is unclear if this drug could prevent microcirculatory dysfunction in septic subjects, improving tissue perfusion and reducing organ failure. Therefore, this study was designed to characterize the microcirculatory effects of ivabradine on a murine model of abdominal sepsis using intravital videomicroscopy. Methods: Twenty-eight golden Syrian hamsters were allocated in four groups: sham-operated animals, nontreated septic animals, septic animals treated with saline, and septic animals treated with ivabradine (2.0 mg/kg intravenous bolus + 0.5 mg · kg−1 · h−1). The primary endpoint was the effect of ivabradine on the microcirculation of skinfold chamber preparations, assessed by changes in microvascular reactivity and rheologic variables, and the secondary endpoint was its effects on organ function, evaluated by differences in arterial blood pressure, motor activity score, arterial blood gases, and hematologic and biochemical parameters among groups. Results: Compared with septic animals treated with saline, those treated with ivabradine had greater functional capillary density (90 ± 4% of baseline values vs. 71 ± 16%; P < 0.001), erythrocyte velocity in capillaries (87 ± 11% of baseline values vs. 62 ± 14%; P < 0.001), and arteriolar diameter (99 ± 4% of baseline values vs. 91 ± 7%; P = 0.041) at the end of the experiment. Besides that, ivabradine-treated animals had less renal, hepatic, and neurologic dysfunction. Conclusions: Ivabradine was effective in reducing microvascular derangements evoked by experimental sepsis, which was accompanied by less organ dysfunction. These results suggest that ivabradine yields beneficial effects on the microcirculation of septic animals.
- 1 January 2017
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 126 (1) , 140-149
Open AccessIvabradine Attenuates the Microcirculatory Derangements Evoked by Experimental Sepsis
Background: Experimental data suggest that ivabradine, an inhibitor of the pacemaker current in sinoatrial node, exerts beneficial effects on endothelial cell function, but it is unclear if this drug could prevent microcirculatory dysfunction in septic subjects, improving tissue perfusion and reducing organ failure. Therefore, this study was designed to characterize the microcirculatory effects of ivabradine on a murine model of abdominal sepsis using intravital videomicroscopy. Methods: Twenty-eight golden Syrian hamsters were allocated in four groups: sham-operated animals, nontreated septic animals, septic animals treated with saline, and septic animals treated with ivabradine (2.0 mg/kg intravenous bolus + 0.5 mg · kg−1 · h−1). The primary endpoint was the effect of ivabradine on the microcirculation of skinfold chamber preparations, assessed by changes in microvascular reactivity and rheologic variables, and the secondary endpoint was its effects on organ function, evaluated by differences in arterial blood pressure, motor activity score, arterial blood gases, and hematologic and biochemical parameters among groups. Results: Compared with septic animals treated with saline, those treated with ivabradine had greater functional capillary density (90 ± 4% of baseline values vs. 71 ± 16%; P < 0.001), erythrocyte velocity in capillaries (87 ± 11% of baseline values vs. 62 ± 14%; P < 0.001), and arteriolar diameter (99 ± 4% of baseline values vs. 91 ± 7%; P = 0.041) at the end of the experiment. Besides that, ivabradine-treated animals had less renal, hepatic, and neurologic dysfunction. Conclusions: Ivabradine was effective in reducing microvascular derangements evoked by experimental sepsis, which was accompanied by less organ dysfunction. These results suggest that ivabradine yields beneficial effects on the microcirculation of septic animals.
- 1 July 2016
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 311 (1) , H24-H35
Microcirculatory dysfunction in sepsis: pathophysiology, clinical monitoring, and potential therapies
Abnormal microvascular perfusion, including decreased functional capillary density and increased blood flow heterogeneity, is observed in early stages of the systemic inflammatory response to infection and appears to have prognostic significance in human sepsis. It is known that improvements in systemic hemodynamics are weakly correlated with the correction of microcirculatory parameters, despite an appropriate treatment of macrohemodynamic abnormalities. Furthermore, conventional hemodynamic monitoring systems available in clinical practice fail to detect microcirculatory parameter changes and responses to treatments, as they do not evaluate intrinsic events that occur in the microcirculation. Fortunately, some bedside diagnostic methods and therapeutic options are specifically directed to the assessment and treatment of microcirculatory changes. In the present review we discuss fundamental aspects of septic microcirculatory abnormalities, including pathophysiology, clinical monitoring, and potential therapies.
- 1 July 2016
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 311 (1) , H24-H35
Microcirculatory dysfunction in sepsis: pathophysiology, clinical monitoring, and potential therapies
Abnormal microvascular perfusion, including decreased functional capillary density and increased blood flow heterogeneity, is observed in early stages of the systemic inflammatory response to infection and appears to have prognostic significance in human sepsis. It is known that improvements in systemic hemodynamics are weakly correlated with the correction of microcirculatory parameters, despite an appropriate treatment of macrohemodynamic abnormalities. Furthermore, conventional hemodynamic monitoring systems available in clinical practice fail to detect microcirculatory parameter changes and responses to treatments, as they do not evaluate intrinsic events that occur in the microcirculation. Fortunately, some bedside diagnostic methods and therapeutic options are specifically directed to the assessment and treatment of microcirculatory changes. In the present review we discuss fundamental aspects of septic microcirculatory abnormalities, including pathophysiology, clinical monitoring, and potential therapies.
- Open Access
- 11 August 2015
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 6, 223
Increment of body mass index is positively correlated with worsening of endothelium-dependent and independent changes in forearm blood flow
Obesity is associated with the impairment of endothelial function leading to the initiation of the atherosclerotic process. We have hypothesized that an increasing impairment of endothelial and vascular smooth muscle cell functions occurs from lean subjects to severe obese ones. Thus, the present study was carried out to investigate the grade of obesity in which endothelial dysfunction can be detected and if there is an increasing impairment of endothelial and vascular smooth muscle cell functions as body mass index increases. According to body mass index, subjects were allocated into five groups: Lean controls, Overweight, Obese class I, Obese class II, and Obese class III. Endothelial and vascular smooth muscle cell functions were evaluated measuring forearm blood flow responses to increasing intra-arterial infusions of acetylcholine and sodium nitroprusside using venous occlusion plethysmography. We observed that forearm blood flow was progressively impaired from lean controls to severe obese and found no significant differences between Lean controls and Overweight groups. Our data suggests that obesity class I is the first grade of obesity in which endothelial dysfunction can be detected and that body mass index positively correlates with the worsening of endothelium-dependent and independent changes in forearm blood flow.
- 11 August 2015
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 6, 223
Open AccessIncrement of body mass index is positively correlated with worsening of endothelium-dependent and independent changes in forearm blood flow
Obesity is associated with the impairment of endothelial function leading to the initiation of the atherosclerotic process. We have hypothesized that an increasing impairment of endothelial and vascular smooth muscle cell functions occurs from lean subjects to severe obese ones. Thus, the present study was carried out to investigate the grade of obesity in which endothelial dysfunction can be detected and if there is an increasing impairment of endothelial and vascular smooth muscle cell functions as body mass index increases. According to body mass index, subjects were allocated into five groups: Lean controls, Overweight, Obese class I, Obese class II, and Obese class III. Endothelial and vascular smooth muscle cell functions were evaluated measuring forearm blood flow responses to increasing intra-arterial infusions of acetylcholine and sodium nitroprusside using venous occlusion plethysmography. We observed that forearm blood flow was progressively impaired from lean controls to severe obese and found no significant differences between Lean controls and Overweight groups. Our data suggests that obesity class I is the first grade of obesity in which endothelial dysfunction can be detected and that body mass index positively correlates with the worsening of endothelium-dependent and independent changes in forearm blood flow.
- Open Access
- 1 March 2015
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 122 (3) , 619-630
Dexmedetomidine Attenuates the Microcirculatory Derangements Evoked by Experimental Sepsis
Intravital microscopy of skinfold chamber microcirculation preparations in unanesthetized golden Syrian hamsters found that dexmedetomidine partially restored lipopolysaccharide-induced capillary perfusion deficits. Dexmedetomidine attenuated both increases in venular leukocyte rolling and adhesion and decreases in functional capillary density and erythrocyte velocity induced by lipopolysaccharide. Background: Dexmedetomidine, an α-2 adrenergic receptor agonist, has already been used in septic patients although few studies have examined its effects on microcirculatory dysfunction, which may play an important role in perpetuating sepsis syndrome. Therefore, the authors have designed a controlled experimental study to characterize the microcirculatory effects of dexmedetomidine in an endotoxemia rodent model that allows in vivo studies of microcirculation. Methods: After skinfold chamber implantation, 49 golden Syrian hamsters were randomly allocated in five groups: (1) control animals; (2) nonendotoxemic animals treated with saline; (3) nonendotoxemic animals treated with dexmedetomidine (5.0 μg kg−1 h−1); (4) endotoxemic (lipopolysaccharide 1.0 mg/kg) animals treated with saline; and (5) endotoxemic animals treated with dexmedetomidine. Intravital microscopy of skinfold chamber preparations allowed quantitative analysis of microvascular variables and venular leukocyte rolling and adhesion. Mean arterial blood pressure, heart rate, arterial blood gases, and lactate concentrations were also documented. Results: Lipopolysaccharide administration increased leukocyte rolling and adhesion and decreased capillary perfusion. Dexmedetomidine significantly attenuated these responses: compared with endotoxemic animals treated with saline, those treated with dexmedetomidine had less leukocyte rolling (11.8 ± 7.2% vs. 24.3 ± 15.0%; P < 0.05) and adhesion (237 ± 185 vs. 510 ± 363; P < 0.05) and greater functional capillary density (57.4 ± 11.2% of baseline values vs. 45.9 ± 11.2%; P < 0.05) and erythrocyte velocity (68.7 ± 17.6% of baseline values vs. 54.4 ± 14.8%; P < 0.05) at the end of the experiment. Conclusions: Dexmedetomidine decreased lipopolysaccharide-induced leukocyte–endothelial interactions in the hamster skinfold chamber microcirculation. This was accompanied by a significant attenuation of capillary perfusion deficits, suggesting that dexmedetomidine yields beneficial effects on endotoxemic animals’ microcirculation.
- 1 March 2015
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 122 (3) , 619-630
Open AccessDexmedetomidine Attenuates the Microcirculatory Derangements Evoked by Experimental Sepsis
Intravital microscopy of skinfold chamber microcirculation preparations in unanesthetized golden Syrian hamsters found that dexmedetomidine partially restored lipopolysaccharide-induced capillary perfusion deficits. Dexmedetomidine attenuated both increases in venular leukocyte rolling and adhesion and decreases in functional capillary density and erythrocyte velocity induced by lipopolysaccharide. Background: Dexmedetomidine, an α-2 adrenergic receptor agonist, has already been used in septic patients although few studies have examined its effects on microcirculatory dysfunction, which may play an important role in perpetuating sepsis syndrome. Therefore, the authors have designed a controlled experimental study to characterize the microcirculatory effects of dexmedetomidine in an endotoxemia rodent model that allows in vivo studies of microcirculation. Methods: After skinfold chamber implantation, 49 golden Syrian hamsters were randomly allocated in five groups: (1) control animals; (2) nonendotoxemic animals treated with saline; (3) nonendotoxemic animals treated with dexmedetomidine (5.0 μg kg−1 h−1); (4) endotoxemic (lipopolysaccharide 1.0 mg/kg) animals treated with saline; and (5) endotoxemic animals treated with dexmedetomidine. Intravital microscopy of skinfold chamber preparations allowed quantitative analysis of microvascular variables and venular leukocyte rolling and adhesion. Mean arterial blood pressure, heart rate, arterial blood gases, and lactate concentrations were also documented. Results: Lipopolysaccharide administration increased leukocyte rolling and adhesion and decreased capillary perfusion. Dexmedetomidine significantly attenuated these responses: compared with endotoxemic animals treated with saline, those treated with dexmedetomidine had less leukocyte rolling (11.8 ± 7.2% vs. 24.3 ± 15.0%; P < 0.05) and adhesion (237 ± 185 vs. 510 ± 363; P < 0.05) and greater functional capillary density (57.4 ± 11.2% of baseline values vs. 45.9 ± 11.2%; P < 0.05) and erythrocyte velocity (68.7 ± 17.6% of baseline values vs. 54.4 ± 14.8%; P < 0.05) at the end of the experiment. Conclusions: Dexmedetomidine decreased lipopolysaccharide-induced leukocyte–endothelial interactions in the hamster skinfold chamber microcirculation. This was accompanied by a significant attenuation of capillary perfusion deficits, suggesting that dexmedetomidine yields beneficial effects on endotoxemic animals’ microcirculation.
- Open Access
- 3 February 2015
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (2) , e0117004
Milrinone Attenuates Arteriolar Vasoconstriction and Capillary Perfusion Deficits on Endotoxemic Hamsters
Apart from its inotropic property, milrinone has vasodilator, anti-inflammatory and antithrombotic effects that could assist in the reversal of septic microcirculatory changes. This paper investigates the effects of milrinone on endotoxemia-related microcirculatory changes and compares them to those observed with the use of norepinephrine. After skinfold chamber implantation procedures and endotoxemia induction by intravenous Escherichia coli lipopolysaccharide administration (2 mg.kg-1), male golden Syrian hamsters were treated with two regimens of intravenous milrinone (0.25 or 0.5 μg.kg-1.min-1). Intravital microscopy of skinfold chamber preparations allowed quantitative analysis of microvascular variables. Macro-hemodynamic, biochemical, and hematological parameters and survival rate were also analyzed. Endotoxemic non-treated animals, endotoxemic animals treated with norepinephrine (0.2 μg.kg-1.min-1), and non-endotoxemic hamsters served as controls. Milrinone (0.5 μg.kg-1.min-1) was effective in reducing lipopolysaccharide-induced arteriolar vasoconstriction, capillary perfusion deficits, and inflammatory response, and in increasing survival. Norepinephrine treated animals showed the best mean arterial pressure levels but the worst functional capillary density values among all endotoxemic groups. Our data suggests that milrinone yielded protective effects on endotoxemic animals’ microcirculation, showed anti-inflammatory properties, and improved survival. Norepinephrine did not recruit the microcirculation nor demonstrated anti-inflammatory effects.
- 3 February 2015
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (2) , e0117004
Open AccessMilrinone Attenuates Arteriolar Vasoconstriction and Capillary Perfusion Deficits on Endotoxemic Hamsters
Apart from its inotropic property, milrinone has vasodilator, anti-inflammatory and antithrombotic effects that could assist in the reversal of septic microcirculatory changes. This paper investigates the effects of milrinone on endotoxemia-related microcirculatory changes and compares them to those observed with the use of norepinephrine. After skinfold chamber implantation procedures and endotoxemia induction by intravenous Escherichia coli lipopolysaccharide administration (2 mg.kg-1), male golden Syrian hamsters were treated with two regimens of intravenous milrinone (0.25 or 0.5 μg.kg-1.min-1). Intravital microscopy of skinfold chamber preparations allowed quantitative analysis of microvascular variables. Macro-hemodynamic, biochemical, and hematological parameters and survival rate were also analyzed. Endotoxemic non-treated animals, endotoxemic animals treated with norepinephrine (0.2 μg.kg-1.min-1), and non-endotoxemic hamsters served as controls. Milrinone (0.5 μg.kg-1.min-1) was effective in reducing lipopolysaccharide-induced arteriolar vasoconstriction, capillary perfusion deficits, and inflammatory response, and in increasing survival. Norepinephrine treated animals showed the best mean arterial pressure levels but the worst functional capillary density values among all endotoxemic groups. Our data suggests that milrinone yielded protective effects on endotoxemic animals’ microcirculation, showed anti-inflammatory properties, and improved survival. Norepinephrine did not recruit the microcirculation nor demonstrated anti-inflammatory effects.
- Open Access
- 24 August 2014
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 12 (1) , 1-13
Fluid resuscitation therapy in endotoxemic hamsters improves survival and attenuates capillary perfusion deficits and inflammatory responses by a mechanism related to nitric oxide
Relative hypovolemia is frequently found in early stages of severe sepsis and septic shock and prompt and aggressive fluid therapy has become standard of care improving tissue perfusion and patient outcome. This paper investigates the role of the nitric oxide pathway on beneficial microcirculatory effects of fluid resuscitation. After skinfold chamber implantation procedures and endotoxemia induction by intravenous Escherichia coli lipopolysaccharide administration (2 mg.kg−1), male golden Syrian hamsters were fluid resuscitated and then sequentially treated with L-Nω-Nitroarginine and L-Arginine hydrochloride (LPS/FR/LNNA group). Intravital microscopy of skinfold chamber preparations allowed quantitative analysis of microvascular variables including venular leukocyte rolling and adhesion. Macro-hemodynamic, biochemical and hematological parameters as well as survival rate were also evaluated. Endotoxemic hamsters treated with fluid therapy alone (LPS/FR group) and non-treated animals (LPS group) served as controls. Fluid resuscitation was effective in reducing lipopolysaccharide-induced microcirculatory changes. After 3 hours of lipopolysaccharide administration, non-fluid resuscitated animals (LPS group) had the lowest functional capillary density (1% from baseline for LPS group vs. 19% for LPS/FR one; p vs. 50% from baseline). Fluid resuscitation also reduced leukocyte-endothelium interactions and sequestration (p vs. LPS/FR group) and increased survival (median survival time: 2 and 5.5 days for LPS and LPS/FR groups, respectively; p <0.05). Nitric oxide synthase inhibition prevented these protective effects, while L-Arginine administration markedly restored many of them. Our results suggest that the underlying mechanism of fluid therapy is the restoration of nitric oxide bioavailability, because inhibition of NOS prevented many of its beneficial effects. Nevertheless, further investigations are required in experimental models closer to conditions of human sepsis to confirm these results.
- 24 August 2014
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 12 (1) , 1-13
Open AccessFluid resuscitation therapy in endotoxemic hamsters improves survival and attenuates capillary perfusion deficits and inflammatory responses by a mechanism related to nitric oxide
Relative hypovolemia is frequently found in early stages of severe sepsis and septic shock and prompt and aggressive fluid therapy has become standard of care improving tissue perfusion and patient outcome. This paper investigates the role of the nitric oxide pathway on beneficial microcirculatory effects of fluid resuscitation. After skinfold chamber implantation procedures and endotoxemia induction by intravenous Escherichia coli lipopolysaccharide administration (2 mg.kg−1), male golden Syrian hamsters were fluid resuscitated and then sequentially treated with L-Nω-Nitroarginine and L-Arginine hydrochloride (LPS/FR/LNNA group). Intravital microscopy of skinfold chamber preparations allowed quantitative analysis of microvascular variables including venular leukocyte rolling and adhesion. Macro-hemodynamic, biochemical and hematological parameters as well as survival rate were also evaluated. Endotoxemic hamsters treated with fluid therapy alone (LPS/FR group) and non-treated animals (LPS group) served as controls. Fluid resuscitation was effective in reducing lipopolysaccharide-induced microcirculatory changes. After 3 hours of lipopolysaccharide administration, non-fluid resuscitated animals (LPS group) had the lowest functional capillary density (1% from baseline for LPS group vs. 19% for LPS/FR one; p vs. 50% from baseline). Fluid resuscitation also reduced leukocyte-endothelium interactions and sequestration (p vs. LPS/FR group) and increased survival (median survival time: 2 and 5.5 days for LPS and LPS/FR groups, respectively; p <0.05). Nitric oxide synthase inhibition prevented these protective effects, while L-Arginine administration markedly restored many of them. Our results suggest that the underlying mechanism of fluid therapy is the restoration of nitric oxide bioavailability, because inhibition of NOS prevented many of its beneficial effects. Nevertheless, further investigations are required in experimental models closer to conditions of human sepsis to confirm these results.